Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Claus Thestrup

CEO, Sweden

Claus Thestrup portrait

Coverage

BoMillFlerieNeoDynamicsPharma Equity GroupAscelia PharmaBioPortoCurasightExpreS2ion Biotech HoldingQlife Holding

Latest content

ShowingAll content types

Ascelia Pharma: Indsender registreringsansøgning (NDA) for Orviglance til FDA

Analyst Comment 04.09.2025, 07.51 by Claus Thestrup
Ascelia Pharma

Bioporto (One-pager): Strong Partnerships, Clear Milestones, Global Potential

Research 03.09.2025, 08.48 by Philip Coombes, Claus Thestrup
BioPorto

Ascelia Pharma: Fenja Capital konverterer SEK 7,5 mio. til aktier

Analyst Comment 03.09.2025, 08.23 by Claus Thestrup
Ascelia Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Gubra: Lancerer 2MW sol- og batteripark i Sorø

Analyst Comment 02.09.2025, 07.48 by Claus Thestrup
Gubra

Pharma Equity Group: Vigtig milepæl for RNX-011

Analyst Comment 01.09.2025, 14.59 by Claus Thestrup, Philip Coombes
Pharma Equity Group

Dagens aktienyheder 29/08: Bioporto, Curasight, Agillic, Gomspace, Impero og Gabriel

Analyst Comment 29.08.2025, 09.01 by Claus Thestrup
BioPortoCurasightAgillicGomSpace Group

Curasight: Video præsentation af Q2 og halvårsregnskabet for 2025

Analyst Comment 29.08.2025, 07.21 by Claus Thestrup
Curasight

Bioporto: ProNephro AKI™ (NGAL) kommercielt tilgængelig i USA

Analyst Comment 28.08.2025, 14.57 by Claus Thestrup
BioPorto

Curasight: Klar til næste kliniske fase – pipeline styrket af kapitaltilførsel

Analyst Comment 28.08.2025, 08.02 by Claus Thestrup
Curasight

ALK: Video præsentation af Q2 og halvårsregnskabet for 2025

Analyst Comment 26.08.2025, 14.53 by Claus Thestrup
ALK-Abelló
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.